ClinicalTrials.Veeva

Menu

Role of Leukocyte- and Platelet-Rich Fibrin Membranes in Endoscopic Endonasal Skull Base Reconstruction

U

Universitaire Ziekenhuizen KU Leuven

Status

Unknown

Conditions

Cranial Sutures; Closure

Treatments

Procedure: Dural closure

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Prospective investigation of the effectivity of L-PRF membranes for skull base reconstruction after endoscopic endonasal skull base surgery (transsphenoidal) versus classical closure techniques.

Full description

The investigators want to demonstrate in a prospective, randomized trial including 220 patients undergoing endoscopic endonasal skull base surgery that the use of L-PRF is non-inferior to classical fibrin sealants.

Approximately 220 patients undergoing cranial surgery will be enrolled in this randomized, controlled, single-blinded multicenter study to evaluate the safety and effectiveness of autologous blood-derived products (L-PRF and fibrinogen) compared to the fibrin sealants as an adjunct for dural repair.

Enrollment

220 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with lesions of the sellar/parasellar region
  • Age > 18 and < 70 years
  • Written informed consent
  • Willingness to adhere to visit schedules

Exclusion criteria

  • Age < 18 and > 70 years
  • Any underlying rhinological condition like nasal polyps, which may interfere with the obtained results
  • Any disorder which might compromise the ability of a patient to give truly informed consent for participation in this study
  • Enrollment in other investigational drug trial(s)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

220 participants in 2 patient groups, including a placebo group

Classical Treatment
Placebo Comparator group
Description:
In this arm, dural closure will be performed with the classical fibrine sealants.
Treatment:
Procedure: Dural closure
L-PRF
Active Comparator group
Description:
In this arm, dural closure will be performed with the autologous L-PRF
Treatment:
Procedure: Dural closure

Trial contacts and locations

3

Loading...

Central trial contact

Laura Van Gerven, prof; Anais Van Hoylandt, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems